| A | B | C | D | E | F | |
|---|---|---|---|---|---|---|
| 1 | Main | |||||
| 2 | Brand | Generic | Economics | Indication | MOA | |
| 3 | Androgel | |||||
| 4 | Kaletra | |||||
| 5 | Niaspan | |||||
| 6 | Rinvoq, fka ABT-494 | upadacitinib | 1 | Rheumatoid Arthritis | JAK | |
| 7 | Survanta | |||||
| 8 | Synagis | AZN | ||||
| 9 | Tricor | |||||
| 10 | Venetoclax, ABT-199 | |||||
| 11 | Zemplar | |||||
| 12 | ABT-267 | ombitasvir | ||||
| 13 | ABT-450 | paritaprevir | ||||
| 14 | ||||||
| 15 | ||||||
| 16 | ||||||
| 17 | ||||||
| 18 | atrasentan | KDNY | DN | |||
| 19 | ABT-179 | modimelanotide | AKI | MCR/alpha-MSH | ||
| 20 | ABT-126 | Alzheimer's | alpha7 | |||
| 21 | ABT-165 | Oncology | VEGF/DLL4 | |||
| 22 | ABT-122 | RA | TNF/IL-17A |